Metformin inhibits high glucose-induced apoptosis of renal podocyte through regulating miR-34a/SIRT1 axis

被引:1
作者
Zhuang, Xudong [1 ]
Sun, Zhuye [2 ]
Du, Huasheng [3 ]
Zhou, Tianhui [4 ]
Zou, Jing [1 ]
Fu, Wei [5 ,6 ]
机构
[1] Linyi Tradit Chinese Med Hosp, Dept Dialysis, Linyi, Shandong, Peoples R China
[2] Rizhao Hosp Tradit Chinese Med, Dept Pharm, Rizhao, Shandong, Peoples R China
[3] Qingdao Municipal Hosp, Dept Nephrol, Qingdao, Shandong, Peoples R China
[4] Beijing Univ Chinese Med, Beijing, Peoples R China
[5] Zibo Cent Hosp, Dept Drug Dispensing, Zibo, Shandong, Peoples R China
[6] Zibo Cent Hosp, Dept Drug Dispensing, 54 Gongqingtuanxi Rd, Zibo 255036, Shandong, Peoples R China
关键词
DN; metformin; miR-34a; podocyte; SIRT1; DIABETIC-NEPHROPATHY; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; MICRORNA-34A; MICROALBUMINURIA; HYPERGLYCEMIA; HYPERTROPHY; CELLS; MICE;
D O I
10.1002/iid3.1053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundPrevious studies have reported SIRT1 was inversely modulated by miR-34a, However, mechanism of metformin (MFN)'s renal podocyte protection under high glucose (HG) conditions and the connection between miR-34a and SIRT1 expression in diabetic nephropathy (DN) remain unclear.MethodWe aimed to further elucidate the role of miR-34a in HG-treated podocytes in DN. A conditionally immortalized human podocyte cell line was cultivated in d-glucose (30 mM).ResultsMicroarray and RT-qPCR revealed that miR-34a was downregulated in HG-treated podocytes. Additionally, miR-34a levels increased in MFN-treated HG-induced podocytes. CCK-8 assay, colony formation assay, flow cytometry, and Western blot detection showed that HG treatment reduced cell viability and promoted via HG treatment, and MFN treatment reversed this phenotypic change. MiR-34a upregulation caused restored cell viability and suppressed cell apoptosis in HG-treated podocytes, and miR-34a downregulation led to damaged cell survival and induced apoptosis in MFN-administered and HG-treated podocytes. The dual luciferase reporter assay showed that SIRT1 3 '-UTR was a direct miR-34a target. Further studies demonstrated an elevation in SIRT1 levels in HG-exposed podocytes, whereas MFN treatment decreased SIRT1 levels. In addition, miR-34a upregulation led to reduced SIRT1 expression, whereas miR-34a inhibition increased SIRT1 levels in cells. MFN-induced miR-34a suppresses podocyte apoptosis under HG conditions by acting on SIRT1.ConclusionThis study proposes a promising approach to interpret the mechanisms of action of the MFN-miR-34a axis involved in DN. Our experimental results show that HG stimulation upregulated miR-34a and suppressed cell viability by upregulating apoptosis in podocytes. MFN attenuates HG-stimulated cell death in podocytes by downregulating miR-34a. Additionally, our data showed that SIRT1 expression was positively correlated with MFN treatment and inversely correlated with miR-34a expression.image
引用
收藏
页数:11
相关论文
共 37 条
[1]   Guidelines Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance [J].
Adler, Amanda I. ;
Shaw, Elizabeth J. ;
Stokes, Tim ;
Ruiz, Francis .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[2]   Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression [J].
Alhaider, Abdulqader A. ;
Korashy, Hesham M. ;
Sayed-Ahmed, Mohamed M. ;
Mobark, Mohammed ;
Kfoury, Hala ;
Mansour, Mahmoud A. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 192 (03) :233-242
[3]   The short-term effect of a switch from glybenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus [J].
Amador-Licona, N ;
Guízar-Mendoza, JM ;
Vargas, E ;
Sánchez-Camargo, G ;
Zamora-Mata, L .
ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (06) :571-575
[4]   Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin [J].
Arunachalam, Gnanapragasam ;
Lakshmanan, Arun Prasath ;
Samuel, Samson Mathews ;
Triggle, Chris R. ;
Ding, Hong .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (02) :314-323
[5]   Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers [J].
Bao, Bin ;
Azmi, Asfar S. ;
Ali, Shadan ;
Zaiem, Feras ;
Sarkar, Fazlul H. .
ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (06)
[6]   Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction [J].
Cavaglieri, Rita C. ;
Day, Robert T. ;
Feliers, Denis ;
Abboud, Hanna E. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 412 (0C) :116-122
[7]   Mir-34a Is Upregulated during Liver Regeneration in Rats and Is Associated with the Suppression of Hepatocyte Proliferation [J].
Chen, Huan ;
Sun, Yimin ;
Dong, Ruiqi ;
Yang, Shengsheng ;
Pan, Chuanyong ;
Xiang, Dao ;
Miao, Mingyong ;
Jiao, Binghua .
PLOS ONE, 2011, 6 (05)
[8]   EGF Receptor Deletion in Podocytes Attenuates Diabetic Nephropathy [J].
Chen, Jianchun ;
Chen, Jian-Kang ;
Harris, Raymond C. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (05) :1115-1125
[9]   Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice [J].
Chen, Peng ;
Chen, Fuchao ;
Lei, Jiexin ;
Li, Qiaoling ;
Zhou, Benhong .
NEUROTHERAPEUTICS, 2019, 16 (04) :1269-1282
[10]   The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics [J].
Conserva, Francesca ;
Pontrelli, Paola ;
Accetturo, Matteo ;
Gesualdo, Loreto .
JOURNAL OF NEPHROLOGY, 2013, 26 (05) :811-820